Get Involved
FOLLOW ON FUNDING
An antimalarial drug targeting Plasmodium phosphodiesterases to cure patients and block transmission; a new tool to combat drug resistance
Dr David Baker (LSHTM), Dr Mark Gardner (Salvensis), Dr Alan Brown (Salvensis), Dr James Duffy (Medicine for Malaria Venture) - £95,216
1 April 2020 to 28 February 2021
Read More
Development of an inactivated oral yeast vaccine against poultry Eimeria
Prof Damer Blake (RVC), Prof Fiona Tomley (RVC), Prof Dirk Werling (RVC), Dr Francesca Soutter (RVC), Dr Matthew Nolan (Cambridge University), Dr Tatiana Küster (Universität Bern) - £91,479
1 March 2020 to 28 February 2021
Read More
Antimicrobial eye drops with extended duration of effect and efficicacy
Prof Liam Good (RVC / Tecrea Ltd), Dr Winnie Ntowboahene (RVC), Chiara Febrarro (Tecrea Ltd), David Cook (Tecrea Ltd), John Ridden (Tecrea Ltd) - £99,939
1 March 2020 to 28 February 2021
Read More
An antimalarial drug targeting Plasmodium phosphodiesterases to cure patients and block transmission; a new tool to combat drug resistance
Prof James Logan (LSHTM), Prof Steve Lindsay (Durham University), Clare Guest (Medical Detection Dogs) - £95,822
1 March 2020 to 28 February 2021
Read More
Optimising sugar attachment site in vaccine
Dr Jon Cuccui (LSHTM), Prof Brendan Wren (LSHTM) - £85,704
1 March 2020 to 28 February 2021
Read More